HON
64
5
EL
42
9
TRV
56
7
PX
62
4
FMC
31
2
BBY
53
5
CMI
56
2
R
72
4
CAT
50
3
MA
67
7
AAL
36
3
EOG
32
-7
STX
77
-5
FOX
57
6
HD
50
6
SPG
50
5
AMAT
58
4
SYK
50
4
MTB
69
5
MCO
71
4
HON
64
5
EL
42
9
TRV
56
7
PX
62
4
FMC
31
2
BBY
53
5
CMI
56
2
R
72
4
CAT
50
3
MA
67
7
AAL
36
3
EOG
32
-7
STX
77
-5
FOX
57
6
HD
50
6
SPG
50
5
AMAT
58
4
SYK
50
4
MTB
69
5
MCO
71
4
Financhill
Back

Royalty Pharma PLC Stock Predictions

Is the Traditional House Obsolete?

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
Sell
48

RPRX
Royalty Pharma PLC

Last Price:
$32.62
Seasonality Move:
-1.38%

7 Day Trial

ALL ACCESS PASS

$ 7

Pacaso, now reserving Nasdaq ticker PCSO, is offering shares at $2.80 until May 29.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.*Pacaso recently received their ticker reservation with Nasdaq

Royalty Pharma PLC Stock Forecast

  • Over the next 52 weeks, Royalty Pharma PLC has on average historically fallen by 4.2% based on the past 4 years of stock performance.
  • Royalty Pharma PLC has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is Royalty Pharma PLC Stock Undervalued?
    The current Royalty Pharma PLC [RPRX] share price is $32.69. The Score for RPRX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • RPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Royalty Pharma PLC Stock Go Up Next Year?

  • Over the next 52 weeks, Royalty Pharma PLC has on average historically fallen by 4.2% based on the past 4 years of stock performance.

Royalty Pharma PLC Stock Rating

Sell
48
Royalty Pharma PLC (RPRX) is a Sell

Is Royalty Pharma PLC overpriced?

  • Royalty Pharma PLC has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Royalty Pharma PLC Stock Price History

Is RPRX stock going to rise?

  • The current trend is moderately bearish and RPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
royaltypharma.com

52-Week Data

52-Week High:
34.32
52-Week Low:
24.05

Prediction Charts

Market Cap:
13.8B
Price in USD:
32.69
Volume:
2.7M
Beta:
0.49

Technical Analysis

SMA50:
32.47
SMA100:
31.91
SMA200:
29.47
52-Wk Change:
22.8%

Stock Predictions

  • Is Royalty Pharma PLC stock public?
    Yes, Royalty Pharma PLC is a publicly traded company.
  • What is the Royalty Pharma PLC stock quote today?
    The Royalty Pharma PLC stock price is 32.69 USD today.
  • How to buy Royalty Pharma PLC stock online?
    You can buy Royalty Pharma PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-7 32.25 32.75 32.83 32.21
May-8 32.62 33.10 34.11 32.37
May-9 33.22 33.15 33.72 33.03
May-12 32.65 33.35 33.60 32.55
May-13 33.09 32.82 33.09 32.55
May-14 32.87 32.29 33.11 32.18
May-15 32.50 33.12 33.13 32.23
May-16 33.08 34.02 34.20 33.06
May-19 34.09 34.25 34.32 33.80
May-20 33.68 33.09 33.80 32.57
May-21 33.15 32.83 33.33 32.81
May-22 32.83 32.31 32.93 32.20
May-23 32.16 32.45 32.60 32.15
May-27 32.64 32.69 32.81 32.21

Royalty Pharma PLC Earnings

Royalty Pharma PLC Earnings Report: Per Share Royalty Pharma PLC Earnings Q1 Q2 Q3 and Q4 last year and next year.

Royalty Pharma PLC Forecast Revenue Growth

Royalty Pharma PLC Stock Analysis: Historical quarterly revenues per share for Royalty Pharma PLC and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.45 per share, an increase this year of $0.37 per share, and an increase next year of $0.62 per share.

* Royalty Pharma PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.